Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients.

@article{Jrgensen2012SignificanceOA,
  title={Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients.},
  author={Trine Lembrecht J\orgensen and Sandra Teiblum and Merete Paludan and Laurids \Ostergaard Poulsen and Anni Young Stensg{\aa}rd J\orgensen and Karin Herskind Bruun and Jesper Hallas and J\orn Herrstedt},
  journal={Gynecologic oncology},
  year={2012},
  volume={127 2},
  pages={367-74}
}
BACKGROUND Age is associated with poor prognosis in ovarian cancer patients. Reasons could be increased comorbidity, more advanced stage, or nonoptimal surgery or chemotherapy. Objectives of this study were to evaluate the significance of comorbidity and age ≥70 years on receiving cytoreductive surgery, standard combination chemotherapy (TC), adherence to TC treatment, and prognosis. METHODS A retrospective cohort study of all women registered in a nation-wide database with ovarian or… CONTINUE READING